U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538882) titled 'AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma' on April 13.
Brief Summary: The precise treatment of primary hepatocellular carcinoma (HCC) highly depends on accurate disease staging (CNLC, TNM, BCLC) and scientific treatment decision-making, which necessitate the integration of both imaging and clinical baseline data. This study prospectively recruits HCC patients and clinical physicians across different hospital tiers to evaluate the clinical value of a self-developed artificial intelligence (AI) model in assisting multi-dimensional comprehensive assessment and treatment decision-making. Utilizing ...